The Victorian Heart Hospital and Victorian Heart Institute, operated by Monash Health in partnership with Monash University, have led a groundbreaking first-in-human trial of a gene-editing therapy that could permanently lower cholesterol and triglyceride levels in people with difficult-to-treat lipid disorders. …
Monash leads world-first trial of cholesterol-lowering gene-editing therapy
November 10, 2025 Latest NewsBioPharmaAustralian Biotech
Latest Video
Georgia Forrest
New Stories
-
The Dispatched Podcast 'Week in Review' - 20 February
February 20, 2026 - - Podcast -
PhRMA launches new campaign against the backdrop of a more assertive U.S.
February 19, 2026 - - Latest News -
Why does anyone accept a review outcome that simply affirms a settled order
February 19, 2026 - - Latest News -
Wesfarmers Health emerges as growth engine after delivering strong first half
February 19, 2026 - - Australian Biotech -
Telix files for European approval of brain cancer imaging candidate TLX101-Px
February 18, 2026 - - Australian Biotech -
IDT signals turnaround as revenue rises and losses narrow under strategic reset
February 18, 2026 - - Latest News -
Nyrada advances lead candidate into mid-stage trial as momentum builds across programs
February 18, 2026 - - Australian Biotech